Intensive group intervention (IGI)	Intensive individual intervention (III)	Continued abstinence at 1 year	1061	1338	Continued abstinence at 12 months confirmed through CO was 7.4% in the III, 5.4% in the IGI, and 1% in the MI. No significant differences were noted between III and MI on the one hand, and between IGI and MI on the other [RR 7.04 (0.9-7.2) and RR 5.1 (0.6-41.9), respectively].
Intensive individual intervention (III)	Minimal intervention (MI)	Continued abstinence at 1 year	1061	1338	Continued abstinence at 12 months confirmed through CO was 7.4% in the III, 5.4% in the IGI, and 1% in the MI. No significant differences were noted between III and MI on the one hand, and between IGI and MI on the other [RR 7.04 (0.9-7.2) and RR 5.1 (0.6-41.9), respectively].
Intensive group intervention (IGI)	Minimal intervention (MI)	Continued abstinence at 1 year	1061	1338	Continued abstinence at 12 months confirmed through CO was 7.4% in the III, 5.4% in the IGI, and 1% in the MI. No significant differences were noted between III and MI on the one hand, and between IGI and MI on the other [RR 7.04 (0.9-7.2) and RR 5.1 (0.6-41.9), respectively].
Intensive group intervention (IGI)	Intensive individual intervention (III)	Continued abstinence at 1 year	1339	1404	No differences were noted between IGI and III [RR 0.7 (0.2-2.2)].
Intensive group intervention (IGI)	Intensive individual intervention (III)	Continued abstinence at 1 year	16240	16571	No differences were observed between the IGI and the III for continued abstinence confirmed by CO [RR 0.7 (0.2-2.2)] or for any of the other secondary outcome measures: self-reported continued abstinence [RR 0.8 (0.3-2.2)]; point abstinence confirmed by CO [RR 0.5 (0.2-1.1)], and self-reported point abstinence [RR 0.8 (0.4-1.8)].
